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Abstract
Background/Aims: Galectin 3 (GAL-3) is a beta galactoside binding lectin that has different 
roles in normal and pathophysiological conditions. GAL-3 has been associated with heart failure 
and was linked to increased risk of death in a number of studies. GAL-3 was found to be up 
regulated in animal models of heart failure as well as myocardial infarction (MI). The objective 
of this study is to test if high GAL-3 after myocardial infarction has a protective role on the 
heart through its anti-apoptotic and anti-necrotic functions. Methods: Male C57B6/J mice and 
GAL-3 knockout (KO) mice were used for permanent ligation of the left anterior descending 
artery of the heart to create infarction in the anterior myocardium. Heart and plasma samples 
were collected 24 hours after the induction of MI and were used for immunohistochemistry, 
Tunnel procedure, electron microscopy and enzyme linked immunosorbent assay (ELISA). 
Results: Our results show that the significant increase in GAL-3 levels in the left ventricle at 
24-hour following MI is associated with significant lower levels of pro-apoptotic proteins; 
cytochrome c, Bax, annexin V, cleaved caspase-3 and a higher levels of anti-apoptotic protein 
Bcl2 in GAL-3 wild MI group than GAL-3 KO group. We also have identified the anti-apoptotic 
activity of GAL-3 is mediated through a significant increase in Akt-1, NF kappa-B and beta- 
catenin proteins. In addition, we have identified the antiapoptotic activity is mediated through 
a significant lower levels of cathepsin-D protein. Conclusion: We conclude that the increased 
levels of GAL-3 at 24-hour following MI regulate antiapoptotic mechanisms in the myocardium 
that will shape the future course of the disease. We also identified that the anti-apoptotic 
mechanisms are likely mediated through interaction of GAL-3 with Akt-1, NF kappa-B, beta- 
catenin and cathepsin D proteins.
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Introduction
Myocardial infarction (MI) is a complex process involving different mechanisms and 
pathways culminating in cardiac structural and contractile dysfunction [1]. Apoptosis is 
one of the mechanisms which mediates cardiac myocyte death during ischemic injury [2-7]. 
Hypoxia has been shown to be the proximate stimulus for myocyte apoptosis [8], and alone 
was able to induce apoptosis in primary cultures of neonatal and adult cardiac myocytes [9]. 
Apoptosis is a highly regulated process in which several regulatory proteins participate. It 
is the balance between these regulatory proteins that decides the fate of the cell. Bax, bcl-2, 
Caspase-3, and cytochrome c are some of these proteins related to apoptosis that have been 
studied in myocardial infarction [10]. Inhibition of apoptosis after MI has the potential to 
reduce infarct size and improve myocardial function. This necessitates identification of key 
regulatory molecules that mediate this mechanism.
Galectin-3 (GAL-3) is a beta galactoside binding lectin that has different roles in normal 
and pathophysiological conditions [11]. It has been associated with heart failure (HF) in 
recent years [12]. Increased level of GAL-3 was linked to recurrent HF and increased risk of 
death in a number of studies [13-16]. GAL-3 was found to be up-regulated in animal models 
of HF even before the development of HF [17] which makes it very interesting to find out 
what happens in the heart when GAL-3 levels are high after MI and before the development 
of HF symptoms and signs.
Previous studies have shown that GAL-3 is involved in apoptosis [18-21]. GAL-3 contains 
the anti-death Asp-Trp-Gly-Arg (NWGR) motif [7, 13] which is critical for its antiapoptotic 
function. The anti-apoptotic activity of GAL-3 was also demonstrated in peritoneal 
macrophages when those from GAL-3-deficient mice were more sensitive to apoptotic 
stimuli than those from control mice [18]. GAL-3 protects cells against apoptosis by working 
through different mechanisms which suggest that GAL-3 regulates the common apoptosis 
commitment step.
As our previous results show substantial increase in the GAL-3 levels in the 
cardiomyocytes, endothelial cells and neutrophil polymorphs in the heart as well as plasma 
at 24 hours post MI time point [19], we hypothesized that high GAL-3 at 24 hours post MI 
time has a protective role on the heart through its anti-apoptotic and anti-necrotic functions. 
We used male C57BL6 mice and GAL-3 KO mice with the same background strain to look for 
apoptotic and necrotic markers at 24-hour post myocardial infarction heart samples.
Materials and Methods
Murine model of myocardial infarction
Male C57B6/J mice (n=16) and GAL-3 KO mice (n=16) were divided into 24 hour MI group and sham 
operated groups. All experimental animal procedures are approved by the Animals Ethics Committee of the 
College of Medicine and Health Sciences, UAE University.
GAL-3 wild and KO mice (male, age: 12-16 weeks; wt: 20-25g) were anesthetized by an intraperitoneal 
injection of Phenobarbitone (70mg/kg). The mice were then intubated by transesophageal illumination 
using a modified 22-gauge plastic cannula and fixed on the operating pad in the supine position by taping all 
four extremities. The mice were connected to a mouse ventilator (Harvard apparatus Minivent Hugo Sachs 
Electronik) which supplied room air supplemented with 100% oxygen (tidal volume 0.2 ml/min., rate 120 
strokes/min). Rectal temperature was continuously monitored and maintained within 36-37°C using a heat 
pad. The lead II ECG (AD Instrument multi-channel recorder interfaced with a computer running Power lab 
4/30 data acquisition software) was recorded from needle electrodes inserted subcutaneously. Myocardial 
infarction was induced in the mice by permanently occluding the left anterior descending coronary artery 
(LAD) as described earlier [20-22].
Briefly, the chest was opened with a lateral incision at the 4th intercostal space on the left side of the 
sternum. Then the chest wall was retracted for better visualization of the heart. With minimal manipulation, 
the pericardial sac was removed and the left anterior descending artery (LAD) was visualized with a 
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stereomicroscope (Zeiss STEMI SV8). An 8-0 ophthalmic silk suture was passed under the LAD and ligated 
1mm distal to left atrial appendage. Occlusion was confirmed by observing immediate paleness of the left 
ventricle post ligation. An accompanying ECG recording showed characteristic ST-Elevation which further 
confirmed ischemia. The chest wall was then closed by approximating the third and fourth ribs with one or 
two interrupted sutures. The muscles were returned back to their original position and the skin closed with 
4-0 prolene suture. The animal was gently disconnected from the ventilator and spontaneous breathing was 
seen immediately. Post operative analgesic (Butorphanol 2mg/kg, s/c, 6 hourly) was given at the end of the 
procedure. Sham- operated mice underwent exactly the same procedure described above, except that the 
suture passed under the LAD is left open and untied. According to the experimental protocol, mice were 
sacrificed 24 hours after induction of myocardial infarction. The hearts were washed in ice cold PBS, right 
ventricle and both atria dissected away and left ventricle was immediately frozen in liquid nitrogen and 
later stored in -80 0 C freezer. Blood was also collected in EDTA vacutainers and centrifuged at 3000 RPM for 
15 minutes. The plasma was collected, alliquoted and stored at -80°C until further analysis. Heart samples 
from the same time point following LAD ligation were fixed in 10% buffered formal-saline for 24 hours.
Protein extraction from samples
Total protein was extracted from heart samples by homogenizing with lysis buffer and collecting 
the supernatant after centrifugation. For total tissue homogenate, the Left ventricular (LV) heart samples 
were thawed, weighed and put in cold lysis buffer containing 50mM Tris, 300mM NaCl, 1mM MgCl2, 3mM 
EDTA, 20mM β-glycerophosphate, 25mM NaF, 1% Triton X-100, 10%w/v Glycerol and protease inhibitor 
tablet (Roche Complete protease inhibitor cocktail tablets). The hearts were homogenized on ice by a 
homogenizer (IKA T25 Ultra Turrax). The samples were then centrifuged at 14000 RPM for 15 minutes at 
4°C, supernatant collected, alliquoted and stored at -80°C until further analysis. Total protein concentration 
was determined by BCA protein assay method (Thermo Scientific Pierce BCA Protein Assay Kit).
Tissue Processing
Hearts were excised, washed with ice-cold phosphate buffer saline (PBS), blotted with filter paper and 
weighed. Each heart was sectioned into coronal slices of 2mm thickness then cassetted and fixed directly 
in 10% neutral formalin for 24 hours, which was followed by dehydration in increasing concentrations of 
ethanol, clearing with xylene and embedding with paraffin.
Immunohistochemistry
Five-um sections were deparaffinized with xylene and rehydrated with graded alcohol. Sections were 
then placed in EnVisionTM FLEX Target Retrieval Solution with a high PH (PH 9) (DAKO Agilent, USA) in a 
water bath at 95oC for 30 minutes. Sections were then washed with distilled water for 5 minutes followed 
by PBS for 5 minutes. Sections were then treated with peroxidase block for 30 minutes followed by protein 
block for 30 minutes. Sections were then incubated for one hour at room temperature with anti- cytochrome 
C antibody (rabbit monoclonal antibody 1:250, Cell Signaling Technology, USA), anti-Bcl2 antibody (Rabbit 
Polyclonal, 1:100, Abcam, USA), anti- cleaved caspase-3 antibody (Rabbit Polyclonal, 1:300, Cell signaling 
technology, USA), anti-Bax antibody (Rabbit Polyclonal, 1:100, Abcam, USA), anti-Wnt-3 antibody (Rabbit 
Polyclonal, 1:100, Abcam, USA), anti-beta-catenin antibody (Rabbit Polyclonal, 1:100, Abcam, USA), anti-
Akt-1 antibody (Rabbit Polyclonal, 1:100, Santacruz biotechnology, USA), anti-phospho-NF kappa B 
antibody (Rabbit Polyclonal, 1:100, Abcam, USA). After conjugation with primary antibodies, sections were 
incubated with secondary antibody (EnVisionTM Detection System, DAKO, Agilent, USA) for 20 minutes at 
room temperature followed by addition of DAB chromogen (EnVisionTM Detection System, DAKO, Agilent, 
USA) and counter staining done with haematoxylin. Appropriate positive controls were used. For negative 
control, the primary antibody was not added to sections. Positive and negative controls were used in every 
batch of stained slides (not shown in figures).
Immunofluorescent labeling
Five-um sections were deparaffinized with xylene and rehydrated with graded alcohol. Sections were 
placed in EnVisionTM FLEX Target Retrieval Solution with a high PH (PH 9) (DAKO Agilent, USA) in a water 
bath at 95oC for 30 minutes. Sections were washed with distilled water for 5 minutes followed by PBS for 
5 minutes. Sections were then incubated with anti-annexin-V antibody (Rabbit Polyclonal,1:100, Abcam, 
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USA), overnight at room temperature. Sections were subsequently incubated with donkey anti-rabbit Alexa 
Fluor 488, (Jackson Immune Research Laboratories, USA, 1:100) antibody. Finally, sections were mounted 
in Dapi-water-soluble mounting media (Abcam, USA) and viewed with Olympus Fluorescent microscope. 
Appropriate positive control sections were used. For negative control, the primary antibody was not added 
to sections and the whole procedure carried out in the same manner as mentioned above. Positive and 
negative controls were used in every batch of stained slides (not shown in figures).
Tunnel Procedure
CardioTACSTM In Situ apoptosis detection kit (TREVIGEN R Helgerman CT, USA) was used to detect 
apoptotic cells. Five-um sections were deparaffinised with xylene and rehydrated with graded alcohol. 
Sections were then placed in PBS for 10 minutes at room temperature. Sections were then covered with 50 
μl of Proteinase K Solution and incubated for 30 minutes at room temperature, followed by washing for 2 
times in deionized water, 2 minutes each. Sections were then immersed in Quenching Solution for 5 minutes 
at room temperature followed by washing for 1 minute at room temperature in deionized water to remove 
peroxide solution. Sections were then immersed in 1X TdT Labeling Buffer for 5 minutes. Sections were 
then covered with 50 μl of Labeling Reaction Mix and incubated at 37oC in humidity chamber for one hour. 
Sections were then immersed in 1X TdT Stop Buffer for 5 minutes at room temperature to stop labeling 
reaction. Sections were then washed 2 times in deionized water for 5 minutes each at room temperature. 
Sections were then covered with 50 μl of Streptavidin-HRP Solution and incubated at room temperature for 
10 minutes. Sections were then washed in several changes of deionized water for 2 minutes each. Sections 
were then covered with 50 μl TACS TM Blue Label for 10 minutes. Sections were then immersed for 5 minutes 
in Nuclear Fast Red followed by washing in deionized water. Sections were then air dried and dehydrated 
with dipping ten times in 95% ethanol and cleared with two changes of p-xylene and mounted with a 
mounting medium.
Morphometric analysis
Morphometric analysis of cytochrome c, Bcl2, cleaved caspase-3, Bax, annexin V, Akt-1, phospho-
NFK-B, Wnt-3, and Beta-Catenin expression in left ventricular cells was done at 24 hours following MI using 
ImageJ software (http://rsbweb.nih.gov/ij/). In addition, apoptotic cells in the left ventricle at 24 hours MI 
detected by cardioTACS in situ tunnel procedure were also analyzed using ImageJ software (http://rsbweb.
nih.gov/ij/).
Cytochrome c, Bcl2, cleaved caspase-3, Bax, annexin V, Akt-1, NFK-B, Wnt-3, and Beta-Catenin labeling 
were determined by counting the number of positive cells in randomly-selected high power fields (HPF) 
in the left ventricle. The mean numbers of positive cells will be converted from per HPF to per mm2 (Each 
mm2= 4HPF). In addition, apoptotic cells labeling by cardioTACS in situ tunnel procedure were determined 
by counting the number of positive cells in randomly-selected high power fields (HPF) in the left ventricle. 
The mean numbers of positive cells will be converted from per HPF to per mm2 (Each mm2= 4HPF).
For, cytochrome c, cleaved caspase-3, Bax, Akt-1, and Wnt-3, labeling, cells were considered positive 
when there was a cytoplasmic staining pattern. For annexin V labeling, cells were considered positive when 
there was a membranous/cytoplasmic staining patterns. For phospho-NFK-B and Beta-Catenin labeling, 
cells were considered positive when there was a nuclear staining pattern.
For apoptotic cells labeled by cardioTACS in situ tunnel procedure, cells were considered positive 
when there was a nuclear staining pattern.
Electron microscopic study
Samples were immediately immersed in McDowell and Trump fixative for 3 h at 25°C. Tissues were then 
rinsed with ethanol and propylene oxide, infiltrated, embedded in Agar-100 epoxy resin, and polymerized 
at 65°C for 24 hours. Blocks were then trimmed and semithin and ultrathin sections were cut with Reichert 
Ultracuts, ultramicrotome. The semithin sections (1 um) were stained with 1% aqueous toluidine blue 
on glass slides. The ultrathin sections (95 nm) on 200 mesh Cu grids were contrasted with uranyl acetate 
followed by lead citrate double stain. The grids were examined and photographed under a Tecnai G2 Spirit 
BioTwin transmission electron microscope.
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Enzyme linked immunosorbent assay
Left ventricular myocardial concentration of cleaved caspase-3, Wnt-3a, Beta-Catenin, Phospho-NF 
kappa-B, Akt-1, and Cathepsin D were determined using enzyme linked immunosorbent assay (ELISA) 
development kits: mouse cleavedcaspase-3 [(DYC 835), R&D Systems, Minneapolis, MN, USA], mouse Wnt-
3a [(DY1324B-05), R&D Systems, Minneapolis, MN, USA], mouse Beta-Catenin [(ab205704), Abcam, USA], 
Phospho-NF kappa-B [(ab176663), Abcam, USA], mouse Akt-1 [(DYC1775-2), R&D Systems, Minneapolis, 
MN, USA], and mouse Cathepsin D, [(ab239420), Abcam, USA] for sandwich ELISA, using standard procedure 
according to the manufacturer’s instructions. The levels were normalized to total protein concentrations.
Briefly, 96-well plates (Nunc-Immuno Plate MaxiSorp Surface (NUNC Brand Products, A/S, Roskilde, 
Denmark), were coated with antibody specific to our proteins of interest. Biotinylated detection antibody 
and streptavidin conjugated horseradish peroxidase were used for detection of captured antigens. The plates 
between steps were aspirated and washed 3 times using ELISA plate washer (BioTek ELx50). Captured 
proteins were visualized using tetramethylbenzidine (TMB)/hydrogen peroxide. Absorbance readings were 
made at 450 nm, using a 96-well plate spectrophotometer (BioTek ELx800). Concentrations in the samples 
were determined by interpolation from a standard curve. Standards and samples were assayed in duplicate.
Statistical analysis
All statistical analyses were done using GraphPad Prism Software version 5. Comparisons between 
the various groups were achieved by one-way analysis of variance (ANOVA), followed by Newman-Keuls 
multiple range tests. Data are presented in mean ± standard error (S.E). P values < 0.05 are considered 
significant.
Results
Antiapoptotic activity of Galectin-3 at 24 hour post MI
Cleaved Caspase 3 Activity. Cleaved Capase-3 activity was measured by ELISA in tissue 
homogenate of LV at 24-hour post MI hearts in the wild type and GAL-3 KO mice. Our 
results show a significant increase in cleaved caspase-3 in the LV of both GAL-3 wild and 
KO groups when compared to their sham 
control groups. Our results also show 
cleaved caspase-3 level is significantly 
higher in GAL-3 KO MI group than 
GAL-3 wild MI group (30700 ± 820.6 
vs 26380 ± 1671 pg/mg, p<0.05) (Fig. 
1). Immunohistochemical staining of 
heart tissue sections showed a granular 
cytoplasmic and nuclear expression of 
cleaved caspase-3 in apoptotic cells in the 
area of infarction in both the GAL-3 wild 
and GAL-3 KO MI groups. The number 
of apoptotic cells that express cleaved 
Caspase-3 was significantly higher in 
GAL-3 KO MI group than GAL-3 wild MI 
group (P<0.001) (Fig. 2J-L).
Fig. 1. The graph represents left ventricular Cleaved 
Caspse-3 at 24-hour post myocardial infarction in wild 
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Fig. 2. Apoptotic and 
anti-apoptotic proteins 
in myocardial infarction. 
A. Representative section 
from the LV of GAL-3 
wild MI group at 24-hour 
following MI showing 
cytoplasmic expression of 
Bcl2 by cardiomyocytes 
in the ischemic area (thin 
arrow). B. Representative 
section from the LV of 
GAL-3 KO MI group at 
24-hour following MI 
showing cytoplasmic 
expression of Bcl2 
by cardiomyocytes 
in the ischemic area 
(thin arrow). C. A 
morphometric graph 
showing a significantly 
higher number of cells 
expressing Bcl2 in the LV 
of GAL-3 wild MI group 
than GAL-3 KO MI group. 
D. Representative section 
from the LV of GAL-3 
wild MI group at 24-hour 
following MI showing 
cytoplasmic expression 
of cytochrome c by 
cardiomyocytes in the 
ischemic area (thin 
arrow). E. Representative 
section from the LV 
of GAL-3 KO MI group at 24-hour following MI showing cytoplasmic expression of cytochrome c by 
cardiomyocytes in the ischemic area (thin arrow). F. A morphometric graph showing a significantly higher 
number of cells expressing cytochrome c in the LV of GAL-3 KO MI group than GAL-3 wild MI group. G. 
Representative section from the LV of GAL-3 wild MI group at 24h following MI showing cytoplasmic 
expression of Bax protein by cardiomyocytes in the ischemic area (thin arrow). H. Representative section 
from the LV of GAL-3 KO MI group at 24-hour following MI showing cytoplasmic expression of Bax protein 
by cardiomyocytes in the ischemic area (thin arrow). I. A morphometric graph showing a significantly 
higher number of cells expressing Bax protein in the LV of GAL-3 KO MI group than GAL-3 wild MI group. J. 
Representative section from the LV of GAL-3 wild MI group at 24-hour following MI showing cytoplasmic 
and nuclear expression of cleaved caspase-3 protein by apoptotic cells in the ischemic area (thin arrow). K. 
Representative section from the LV of GAL-3 KO MI group at 24-hour following MI showing cytoplasmic and 
nuclear expression of cleaved caspase-3 protein by apoptotic cells in the ischemic area (thin arrow). L. A 
morphometric graph showing a significantly higher number of cells expressing cleaved caspase-3 protein in 
the LV of GAL-3 KO MI group than GAL-3 wild MI group. M. Representative section from the LV of GAL-3 wild 
MI group at 24-hour following MI showing membranous expression of annexin V protein by apoptotic cells 
in the ischemic area (thin arrow). N. Representative section from the LV of GAL-3 KO MI group at 24-hour 
following MI showing membranous expression of annexin V protein by apoptotic cells in the ischemic area 
(thin arrow). O. A morphometric graph showing a significantly higher number of cells expressing Annexin 
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Bcl2 activity. Immunohistochemical expression of Bcl2 protein was cytoplasmic and 
mainly seen in the cardiomyocytes. There was a significantly higher number of cells expressing 
Bcl2 protein in both GAL-3 wild (P<0.001) and GAL-3 KO (P<0.01) MI groups as compared 
to their sham control groups. There was a significant higher number of LV cardiomyocytes 
expressing Bcl-2 protein in GAL-3 wild type mice than GAL-3 KO mice (P<0.001) (Fig. 2A-C).
Cytochrome C activity. Immunohistochemical expression of cytochrome c protein was 
cytoplasmic and mainly seen in the cardiomyocytes. There was a significantly higher number 
of cells expressing cytochrome c in both GAL-3 wild (P<0.01) and GAL-3 KO (P<0.001) 
MI groups as compared to their sham control groups. The number of LV cardiomyocytes 
expressing cytochrome c protein at 24-hour MI was also significantly higher in the GAL-3 KO 
mice than GAL-3 wild mice (P<0.01) (Fig. 2D-F).
Bax activity. Immunohistochemical expression of Bax protein was cytoplasmic and 
mainly seen in the cardiomyocytes. There was a significantly higher number of cells 
expressing Bax protein in both GAL-3 wild (P<0.001) and GAL-3 KO (P<0.001) MI groups as 
compared to their sham control groups. The number of LV cardiomyocytes expressing Bax 
protein at 24-hour MI was also significantly higher in the GAL-3 KO mice than GAL-3 wild 
mice (P<0.01) (Fig. 2G-I).
Annexin V activity. There was membranous staining of Annexin V to apoptotic cells in 
the LV at 24-hour MI. There was a significantly higher number of cells expressing annexin v 
in both GAL-3 wild (P<0.001) and GAL-3 KO (P<0.001) MI groups as compared to their sham 
control groups. There was also significantly higher number of cells stained with annexin V in 
GAL-3 KO mice as compared with GAL-3 wild mice (P<0.001), (Fig. 2M-O).
Tunnel Procedure. Apoptotic cells show granular blue nuclear staining. There was a 
significantly higher number of apoptotic cells in both GAL-3 wild (P<0.001) and GAL-3 KO 
(P<0.001) MI groups as compared to their sham control groups. The number of apoptotic 
cells were significantly higher in GAL-3 KO MI group than GAL-3 wild MI group (P<0.01) 
(Fig. 3).
Cathepsin-D Activity. Cathepsin D activity was measured by ELISA in the tissue 
homogenate of LV of 24 hour post MI hearts in GAL-3 wild and GAL-3 KO MI groups. There 
were significantly higher levels of cathepsin D protein in both GAL-3 wild (P<0.01) and GAL-
3 KO (P<0.001) MI groups as compared to their sham control groups. Moreover, there was a 
significantly higher levels of cathepsin D in GAL-3 KO MI group (63.21 ± 1.939 pg/mg) than 
GAL-3 wild MI group (43.88 ± 2.112 pg/mg ) (P<0.001) (Fig. 4).
Electron Microscopic study. Ultrathin sections from cardiomyocytes of GAL-3 wild and 
GAL-3 KO MI mice show significant damage to mitochondria, rough endoplasmic reticulum, 
muscle fibrils, sarcolemmal membrane and nucleus in ischemic area at 24-hour following 
MI. An increased lysosomal activity was also seen however more lysosomes are seen in 
cardiomyocytes of GAL-3 KO MI group than GAL-3 wild MI group. There was increase in 
apoptotic bodies and cells in the myocardium at 24-hour MI. Examining ultrathin sections 
show a higher number of apoptotic bodies and cells in the myocardium of GAL-3 KO group 
than GAL-3 wild group (Fig. 5).
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Fig. 3. CardioTACSTM In Situ apoptosis detection. A&C. Representative section from the LV of GAL-3 wild 
MI group at 24h following MI showing blue nuclear staining of apoptotic cells in the ischemic area (thin 
arrow). B&D. Representative section from the LV of GAL-3 KO MI group at 24-hour following MI showing 
blue nuclear staining of apoptotic cells in the ischemic area (thin arrow). E&F. A high power views show blue 
nuclear staining of apoptotic cardiomyocytes in the ischemic area (thin arrow). G. A morphometric graph 
showing a significantly higher number of blue-stained apoptotic cells in the LV of GAL-3 KO MI group than 



















Fig. 4. The graph represents left ventricular 
cathepsin D protein at 24-hour post myocardial 
infarction in wild type C57BL6 and GAL-3 KO mouse 
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Galectin-3 and Cell survival pathways
Total Akt-1 and phospho-Akt activity. Total Akt-1 protein was measured in LV tissue 
homogenates by ELISA and showed a significantly higher level in GAL-3 wild MI group when 
compared to sham control group (P<0.01), while GAL-3 KO MI group showed no significant 
difference from its sham control group. There was a significantly higher level of Akt-1 protein 
in GAL-3 wild MI group (2225 ± 156.2 pg/mg)than GAL-3 KO MI group (1816 ± 84.76 pg/
mg), (P<0.01) (Fig. 6A).
In addition, heart sections stained for phospho-Akt showed a significantly higher 
number of stained cells in GAL-3 wild type than GAL-3 KO groups (P<0.001) (Fig. 7A-C).
Fig. 5. Electron microscopic feature of 
cardiomyocytes at 24-hour following MI. A, 
C, E, G and I: Representative ultrathin section 
of cardiomyocyte from GAL-3 wild MI group 
showing A, damaged myofibrils (thin arrow) and 
damaged mitochondria (curved arrow). C, dilated 
rough endoplasmic reticulum (arrowhead), 
nuclear chromatin lysis (thin arrow), damaged 
microorganelle in a lysosome (thick arrow), 
and damaged mitochondria (curved arrow). 
E, Pyknotic nucleus with irregular nuclear 
membrane as early apoptotic nuclear changes 
in cardiomyocytes. G, two apoptotic bodies 
(arrowhead). I, apoptotic bodies (arrowhead) 
and one apoptotic nuclear changes (thin arrow). 
B, D, F, H and J: Representative ultrathin section 
of cardiomyocyte from GAL-3 KO MI group 
showing B, dilated rough endoplasmic reticulum 
(arrowhead), damaged mitochondria (curved 
arrow), lysosomes (thick arrow), damaged 
myofibrils (thin arrow), apoptotic cell (double 
arrowhead). D, damaged myofibrils (arrowhead), 
damaged mitochondria (curved arrow)and 
damaged sarcolemmal membrane (thin arrow). 
F, damaged myofibrils (arrowhead), damaged 
mitochondria (curved arrow), lysosomes (thick 
arrow), and apoptotic bodies (arrowhead). H, 
multiple apoptotic bodies (arrowhead) and 
apoptotic cells (thin arrow). J, multiple apoptotic 
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Phospho-NF Kappa-B. Phospho-NF kappa-B 
protein was measured in LV tissue homogenates by 
ELISA and showed significantly higher levels in GAL-
3 wild (P<0.001) and GAL-3 KO (P<0.01) MI groups 
as compared to their sham control groups. Moreover, 
there was a significantly higher levels of phospho-NF 
kappa-B in GAL-3 wild MI group (1.018 ± 0.07133 pg/
mg) than GAL-3 KO MI group (0.7853 ± 0.01795 pg/mg) 
(P<0.001), (Fig. 6B).
In addition, heart sections stained for phospho-
NF Kappa-B showed a significantly higher number of 
nuclear-stained cells in GAL-3 wild type than GAL-3 KO 
groups (P<0.05) (Fig. 7D-F).
Wnt/beta-catenin pathway. Beta-catenin protein 
was measured in LV tissue homogenates by ELISA 
and showed significantly higher levels in both GAL-3 
wild (P<0.001) and GAL-3 KO (P<0.01) MI groups as 
compared to their sham control groups. Moreover, there 
was a significantly higher levels of beta-catenin protein 
in GAL-3 wild MI group (10.71 ± 0.9369 pg/mg) than 
GAL-3 KO MI group (8.635 ± 0.2974 pg/mg) (P<0.05), 
(Fig. 6C).
In addition, heart sections stained for Beta-catenin 
protein showed a significantly higher number of nuclear-
stained cells in GAL-3 wild type than GAL-3 KO groups 
(P<0.01) (Fig. 7G-I).
Discussion
GAL-3 has diverse functions depending upon its 
localization within the tissue. It may be extracellular, 
cytoplasmic or nuclear [23-26]. Understanding the 
precise function of GAL-3 in regulating different 
biological functions requires specific in vivo model 
systems [27]. Our model is a murine model of MI where 
the LV has undergone infarction and the LV as a whole is 
used to look for changes that may have occurred in both 
GAL-3 wild and KO hearts.
Previously we have shown that after 24 hours of 
permanent ligation of LAD, the LV tissue of GAL-3 wild 
mice showed a significant higher level of GAL-3 in MI 
group when compared with corresponding sham group 
and that it was being produced by cardiomyocytes, 
endothelial cells and neutrophils [19]. This significant 
increase prompted us to investigate the role of GAL-3 in 
relation to apoptosis and necrosis in the heart.
There are two major apoptotic pathways namely 
intrinsic and extrinsic pathway. Intrinsic apoptotic 
signaling causes cytochrome c release from the 
mitochondria. Cytochrome c in the cytosol initiates 
the formation of “apoptosome,” which consists of 
cytochrome c, caspase adaptor proteins such as Apaf-1, 
Fig. 6. A. The graph represents 
Total Akt-1 concentrations (pg/
mg) at 24-hour post myocardial 
infarction in wild type C57BL6 and 
GAL-3 KO mouse heart. B. The graph 
represents phospho-NF kappa-B 
concentrations (pg/mg) at 24-hour 
post myocardial infarction in wild 
type C57BL6 and GAL-3 KO mouse 
heart. C. The graph represents beta-
catenin concentrations (pg/mg) at 
24-hour post myocardial infarction 
in wild type C57BL6 and GAL-3 KO 
mouse heart. Note: P value<0.05 is 
considered statistically significant.
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and caspases [28-30] and results in caspase activation, a commitment step for apoptosis 
induction. While, extrinsic apoptotic signals are mediated by cell-surface death receptors, 
including tumor necrosis factor, Fas and TRAIL receptor families. The death domains of the 
death receptor form the “death-inducing signaling complex,” where caspases are activated.
The active or cleaved caspase- 3 acts on a number of death substrates that lead to 
the characteristic hallmarks of apoptotic cell; DNA and nuclear fragmentation, membrane 
blebbing and other morphological and biochemical alterations [31, 32].
Studies have shown that apoptosis can occur in cardiac myocytes after 3 hours of acute 
MI in mice [8], rats [33] and humans [34]. However, the exact mechanism is not completely 
clear.
Fig. 7. A. Representative section from the LV of GAL-3 wild MI group at 24h following MI showing cytoplasmic 
expression of Akt-1 protein by cardiomyocytes in the ischemic area (thin arrow). B. Representative section 
from the LV of GAL-3 KO MI group at 24h following MI showing cytoplasmic expression of Akt-1 protein by 
cardiomyocytes in the ischemic area (thin arrow). C. A morphometric graph showing a significantly higher 
number of cells expressing Akt-1 protein in the LV of GAL-3 wild MI group than GAL-3 KO MI group. D. 
Representative section from the LV of GAL-3 wild MI group at 24h following MI showing nuclear expression 
of phospho-NF kappa-B protein by cardiomyocytes in the ischemic area (thin arrow). E. Representative 
section from the LV of GAL-3 KO MI group at 24h following MI showing nuclear expression of phospho-NF 
kappa-B protein by cardiomyocytes in the ischemic area (thin arrow). F. A morphometric graph showing 
a significantly higher number of cells with nuclear expression of phospho-NF kappa-B protein in the LV 
of GAL-3 wild MI group than GAL-3 KO MI group. G. Representative section from the LV of GAL-3 wild MI 
group at 24h following MI showing nuclear expression of beta-catenin protein by cardiomyocytes in the 
ischemic area (thin arrow). H. Representative section from the LV of GAL-3 KO MI group at 24h following MI 
showing nuclear expression of beta-catenin protein by cardiomyocytes in the ischemic area (thin arrow). I. A 
morphometric graph showing a significantly higher number of cells with nuclear expression of beta-catenin 
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GAL-3 has been found to be critically involved in apoptosis depending on its subcellular 
localization. Intracellular GAL-3 can inhibit apoptosis [35] whereas extracellular GAL-3 
induces apoptosis [36]. Immunohistochemistry in our previous study [19], however, is 
showing intracellular localization of GAL-3. In this study we have examined the role of GAL-
3 in apoptosis at 24-hour following MI, therefore, we have used GAL-3 KO mice to verify 
its role. Consequently, the post-MI antiapoptotic response was studied in the presence and 
absence of GAL-3.
Our results show that proapoptotic protein like cleaved caspase-3, Bax and cytochrome 
c, are significantly higher in the LV of GAL-3 KO MI group than GAL-3 wild MI group. We 
have also identified a significantly higher number of apoptotic cells expressing annexin v in 
the LV of GAL-3 KO group than GAL-3 wild type. In addition, tunnel procedure has shown a 
significant higher number of apoptotic cells in the LV of GAL-3 KO group than GAL-3 wild 
type. Electron microscopic examination of LV myocardium also shows a higher number of 
apoptotic bodies in GAL-3 KO MI group than GAL-3 wild MI group.
We have also checked anti apoptotic activity of Bcl-2 protein and found that its expression 
is considerably reduced in the LV of GAL-3 KO compared to GAL-3 wild type.
Our results are obviously showing the levels of studied LV proapoptotic and antiapoptotic 
proteins being significantly affected by the presence or absence of GAL-3, suggesting that at 
24- hour post MI time, GAL-3 is controlling the apoptotic pathway by down regulating the 
proapoptotic proteins and increasing the anti-apoptotic Bcl-2. Literature has many reports 
regarding anti-apoptotic role of GAL-3. GAL-3 translocates to the perinuclear membrane 
following apoptotic stimuli [37, 38]. It is enriched in the mitochondria and prevents 
mitochondrial damage and cytochrome c release [35].
We have also shown a higher level of cathepsin D in the LV of GAL-3 KO MI group than 
GAL-3 wild MI group. Cathepsin D is a lysosomal protease expressed in all tissues and 
involved in nonspecific protein degradation in a strongly acidic environment of lysosomes 
[39].
Cathepsin D has been implicated in lysosome-related cell death [40]. It has been shown 
to control early processes in lysosome-mediated necrosis [41]. Lysosomes contribute to 
necrosis if complete lysosomal rupture occurs but also can drive apoptosis due to the release 
of cathepsins, into the cytosol as a consequence of lysosomal membrane permeabilization 
[42]. Porte Alcon et al. have shown increased Cathepsin D is involved in regulated necrosis 
[43]. Hence, the increased level of cathepsin D in tissue is usually seen in parallel with the cell 
death. Moreover, cathepsins have been widely implicated in apoptosis [44]. They are released 
into the cytosol as active enzymes where they can interact with a variety of apoptotic pathway 
substrates [45] which will contribute to caspase dependent and independent apoptosis with 
or without mitochondrial involvement [46]. Our finding of lower level of cathepsin D in the 
LV of GAL-3 wild MI group than GAL-3 KO MI group suggests a antiapoptotic role of GAL-3 
at 24- hour MI.
GAL-3 has been linked to pro survival signal transduction pathways in previous studies. 
GAL-3 was shown to inhibit TNF- induced apoptosis through activation of Akt [45]. Also 
GAL-3 was found to enhance the PI3K/Akt activity, resulting in Tumor Necrosis Factor–
Related Apoptosis-Inducing Ligand (TRAIL) resistance and inhibition of apoptosis [47]. Akt-
1 is an anti-apoptotic protein, activated by phospholipid products of phosphatidylinositol 
3-kinase (PI3K) and is a downstream target of PI3K in cell survival signaling [48]. We found 
significantly higher levels of total Akt-1 in the LV of GAL-3 wild MI group than GAL-3 KO MI 
group at 24-hour post MI. This supports the anti-apoptotic activity of GAL-3 being mediated 
through activation of Akt-1.
NF-κB is a transcription factor that plays important roles in regulating Inflammation, cell 
proliferation and cell survival. Phosphorylation plays a critical role in the activation of NF-κB 
downstream of all these stimuli [49]. NF-κB is now recognized as an important contributor 
to cell survival and protection from apoptosis [50, 51]. We have identified a significantly 
higher level of phosphorylated-NF kappa B in the LV in GAL-3 wild group than GAL-3 KO 
group. This is confirmed by higher nuclear stained cells with NF-κB in the LV at 24h MI 
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in GAL-3 wild group than GAL-3 KO mice. Interestingly, GAL-3 transcription under hypoxic 
conditions is triggered in an HIF-1α and NF-κB dependent manner. Thus, overexpression of 
GAL-3 is part of an adaptive program leading to tumor cell survival under these stressful 
conditions [52]. Studies have shown NF-kappaB to be involved in the induction of GAL-3 [53] 
as well as GAL-3 is involved in the activation of NF-κB [54]. These findings suggest that the 
anti-apoptotic role of GAL-3 can also be mediated through activation of NF-κB.
The Wnt proteins has been shown to have protective effects on injured cells through 
its anti-apoptotic function via activation of β-catenin and c-Myc [55-57]. Wnt initiates 
canonical signaling by binding the Frizzled receptor and LRP co-receptor. This signals the 
phosphoprotein disheveled to traffic the destruction complex (Axin, CK1α, APC, GSK-3β) 
to the plasma membrane, allowing for translocation of β-catenin to the nucleus to activate 
transcription. GAL-3 has been found to be a novel binding partner of β-catenin [58]. We have 
shown an increase in the levels of β-catenin in the LV at 24-hour MI. We have also shown a 
significantly higher level of β-catenin in the LV of GAL-3 wild group than in GAL-3 KO group, 
which was confirmed by higher nuclear stained cells with β-catenin in the LV at 24-hour MI 
in GAL-3 wild group than GAL-3 KO mice, suggesting that GAL-3 can induce anti-apoptotic 
effect through activation of β-catenin. This finding is supported by work done by Song etal 
and Chen et al. which show Wnt signaling inhibits apoptosis by activating beta-catenin/T cell 
factor-mediated transcription [59, 60].
GAL-3 seems to link these pro survival signal transduction pathways investigated in our 
study.  These pathways also have cross talk between them at various levels. For example, 
Wnt/β-catenin pathway players modulate many of their effects through interaction with NF-
κB and reciprocally NF-κB also influences the Wnt/β-catenin signaling pathway [61], so it 
is understandable that GAL-3 is playing a central connector role in the pro survival signal 
transduction pathways.
Our study demonstrates that at 24-hour following MI the presence or absence of 
intracellular GAL-3 is associated with significant changes in proapoptotic and antiapoptotic 
proteins, and that the high GAL-3 levels in the myocardium is mediating an anti-apoptotic 
environment that may shape the future course of the disease. Anti-apoptotic mechanism in 
cardiomyocytes on one hand may be beneficial as it may protect the cardiomyocytes against 
death and prevent myocyte loss but on the other hand may prove to be deleterious as the 
rescued cardiomyocytes may not remain functional or may undergo necrosis later. Apoptosis 
may be viewed as a mechanism by which the heart limits the extent of a more destructive 
process of necrosis with its accompanying inflammation [8]. Inhibition of apoptosis in the 
neutrophil polymorphs can prolong their stay in the infarcted myocardium potentiating the 
effect of inflammation and destruction [62]. Apoptosis can therefore be considered a double-
edged sword, which can work in either way.
Functional studies are very important, however, it was not our primary goal in this study 
and it will be considered in our future studies.
Conclusion
We conclude that the increased levels of GAL-3 at 24-hour following MI regulate 
antiapoptotic mechanisms in the myocardium that will shape the future course of the 
disease. We also identified that the anti-apoptotic mechanisms are likely mediated through 
interaction of GAL-3 with Akt-1, NF kappa-B, Wnt3a, beta- catenin and cathepsin D proteins.
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